Web Analytics Made Easy - StatCounter

Aminosalicylic Acid Tab Tenders

Get complete information related to latest Aminosalicylic Acid Tab Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Aminosalicylic Acid Tab Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Aminosalicylic Acid Tab Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :36195586 Due date: 05 Jun, 202405 Jun, 2024 2.34 Lacs
Tender For supply of drugs and pharamceutical products - echs re13 tab carbimazole 10 mg , echs re13 tab cefuroxime 500 mg tab , echs re13 tab clozapine 50mg , echs re13 tab cough lozenges , echs re13 tab cyclophosphamide 50mg , echs re13 tab danazole 200mg , echs re13 tab diclofenac k 50mg trypsin chymotrypsin 50000 iu chymoral plus , echs re13 tab dolutegravir 50mg lamivudine 300mg tenofovir 300mg , echs re13 tab dosulepin 25mg , echs re13 tab duloxetin 30mg , echs re13 tab ebandronate 150 mg , echs re13 tab epleneron 25 mg planep , echs re13 tab esomeprazole 40mg , echs re13 tab etodolac 400mg , echs re13 tab fenofibrate 160mg , echs re13 tab ferric citrate 210 mg auryxia , echs re13 tab finasteride 1mg , echs re13 tab finerenone 10 mg , echs re13 tab flecainidee 50mg , echs re13 tab gingo biloba , echs re13 tab gliclazide 80 mg , echs re13 tab hyoscine butyl bromide 10 mg , echs re13 tab isolazine 57 dot 5mg , echs re13 tab itopride 150 mg plus esomeprazole 40mg , echs re13 tab lenvatinib 4mg , echs re13 tab lenvatinib 8mg , echs re13 tab levocetirizine 2 dot 5mg plus paracetamol 325mg plus pseudoephedrine 60mg tab , echs re13 tab levosulpride 50 mg , echs re13 tab losartan 50 mg plus amlodipine 5 mg , echs re13 tab mebeverine hcl 200mg , echs re13 tab mecobalamine 500mcg , echs re13 tab merabegarone 25 mg , echs re13 tab mesalamine 1 dot 2 mg , echs re13 tab metolazone 2 dot 5mg , echs re13 tab mirabegron 25mg , echs re13 tab monoxididine 0 dot 3mg , echs re13 tab monteleucost 10 mg plus tab fexafenadine 120 mg , echs re13 tab moxovas 0 dot 3 mg , echs re13 cr kojic acid 2 percent niacinamide 4 percent soy isoflavones 0 dot 2 percent tettrahydrocurcumin 0 dot 1 percent tube of 15gm , echs re13 sitagliptin 50mg tab bid number/ ( ( ) ): gem/2024/b/4945914 dated/* : 15-05-2024 bid document/ 2 1 / 33

Central Government/Public Sector

CTN :36175557 Due date: 24 May, 202424 May, 2024 NA
Tender For supply of hyoscine butyl bromide injection 20mg / ml 1ml amp

Central Government And Public Sector

CTN :36170049 Due date: 13 May, 202413 May, 2024 NA
Tender For supply of hyoscine butyl bromide 20mg/ml- 1ml injection

CTN :36136558 Due date: 24 May, 202424 May, 2024 73.51 Lacs
Tender For supply of ifa 54 drugs - anti haemorhoidal ointment containing betamethasone 0point05percentageco , att fixed dose combination rifampicin 150 mgcomma isoniazid 75 mgcomma , beclomethasone dipropionate 50mcg and levosalbutamol 50mcg per metred dose , bimatoprost 0point01percentagewith bak 0point02percentage bott of 3ml , bromhexine syp 5ml containing 4mg of bromhexine hclcomma bottle of 100ml , caffeine citrate 20mgperml injcomma 1ml vial , ciprofloxacin 0point3percentage eye drops of 3mgperml bott of 5ml , dinoprostone gel 0point5 mg in 3 gmper2point5 ml gel persyringe , escitalopram 5 mg tab , eye drop brimonidine 0point2percentage plus brinzolamide 1percentagecomma bottle of 5ml , eye drop povidone 20mgpermlcomma preservative freecomma phosphate , homatropine hydrochloride soln 2percentage , human milk fortifier 2gm sachet , hydroxy methyl cellulose 2percentagecomma 2ml inj , imipramine 25 mg tab , iron syp paediatriccomma each 5ml containing elemental iron 25 50mg and folic , isapgolperispaghula husk 3point5gm , lignocaine 1percentage for intra ocular use vial of 1ml preservative free , mesalazine 1point2 gm sr 5 aminosalicylic acid tab , methylphenidate hydrochloride 18 mg er tab , mometasone furoate monohydrate nasal spray 50mcg per puff in 10 ml bottle , moxifloxacin 5gm eye ointment , moxifloxacin hcl 0point5percentage plus dexamethasone 0point1percentage , moxifloxacin hydrochloride 5 mg and dexamethasone phosphate , multivitamin drops with constituents having vit acomma vit b1com , 0point5percentage chlorhexidine acetate tulle grass dressing , acyclovir ophth ointment 3percentage wperw in 5gm tube , atomoxetine 10mg tab , bisacodyl 5mg tab , calcium phosphate 0point24mgper5mlcomma syp , cefaclor syp 125mgper5ml bott of 30ml , ciprofloxacin hcl 0point3percentage plus dexamethasone 0point1percentage eye , cisatracurium besytlate inj 20 mg per 10 mi vial of 10 ml , clomiphene citrate 50 mgpoint tab , clonazepam 0point25 mg tab , dorzolamide 2percentage plus timolol 0point05percentage eperd , eperd ripasudil 0point4percentagecomma bott of 5 ml , ethambutol 800mg tab , fexofenadine hydrochloride 120mg tab , fluconazole 0point3percentage wperv bott of 5ml , fluvoxamine 100 mg cap , glucosamine 500mg tab , human insulin analogue rapid acting injcomma 100 ipointupoint per ml r , inj hyaluronidase 1500iu , linagliptin 5mg tab , metronidazole inj for iv use containing 500mg per bott of 100ml

CTN :36090788 Due date: 27 May, 202427 May, 2024 NA
Tender For rate contract for supply of generic drugs for a period of 02 years from date of conclusion - , colchicine tablet i.p. 0.5 mg, aceclofenac and paracetamol tablet 100mg + 650mg, diclofenac potassium and thiocholchiside tablet 50mg + 8mg, paracetamol ip (as immediate release) 300mg, paracetamol ip (as sustained release) 700mg., apremilast 10 mg, apremilast 20 mg, aceclofenac 100mg + praracetamol 325mg + thiocolchicoside 8mg, aceclofenac 100mg+paracetamol 325mg+thiocolchicoside 4mg, iguratimod 25mg, paracetamol 162.5mg+tramadol 18.75mg, sodium hyaluronate 20mg, bilastine 10 mg + montelukast 4 mg, bilastine 20mg, bilastine 20mg+montelukast 10mg, ondanseetron 4 mg oral disintegrating strip each orally disintegrating strip contains: ondansetron hydrochloride ip equivalent to ondansetron 4 mg, ondanseetron 8 mg oral disintegrating strip each orally disintegrating strip contains: ondansetron hydrochloride ip equivalent to ondansetron 8 mg, iron sucrose 50 mg/ml inj., calcium dobesillate tablet 500 mg, elemental iron, folic acid and zinc sulphate monohydrate capsule 152mg + 750mcg + 22.5mg, betamethasone and neomycin cream 0.10%w/w + 0.5%w/w, clotrimazole 1%+selenium 2.5% suspension, gum karaya and sennosides powder 3.1g + 18.0mg, ketoconazole and prepared coal tar scalp solution 2%w/v + 2%w/v, methoxsalen lotion 1%, beclometasone 0.025%+lidocaine 2.50%+phenylephrine 0.10% ointment, sodium fusidate ip eq. to fusidic acid ip 2% w/w, bottle a: diperoxochloric acid 1.16mg bottle b: sterile sodium chloride solution bp 0.9%w/v, cadexomer iodine 500mg (eq. to 0.9% w/w iodine), cadexomer iodine 1000mg, molecular iodine stabilized 1500 ppm, melatonin 0.3mg/0.2ml, feracrylum gel 3%w/w centbucridine 0.5%w/w, adapalene 0.1%+benzoyl peroxide 2.5%, allantoin 0.01gm+allium cepa 0.1gm+heparin 50iu, amorolfine 0.25%, amorolfine 5%, beclometasone 0.25%+sertaconazole nitrate 2%, calcipotriol 0.5%+clobetasol 0.05%, calcitriol 0.3%+clobetasol 0.5%, capsaicin based rubefacients 0.035%+gabapentin 8%+ketoprofen 5%+methyl salicylate 5%, chlorhexidine gluconate 0.2%+silver sulfadiazine (nanonized) 0.5%, clobetasol 0.05%+salicylic acid 3.5%, clobetasol 0.05%+salicylic acid 6%, eberconazole 1%, fusidic acid 2%+mometasone 0.1%, halobetasol 0.05%, halobetasol 0.05%+salicylic acid 3%, pimecrolimus 1%, sertaconazole 2%, furosemide 40mg, spironolactone 50mg+torasemide 5mg, magaldrate and simethicone chewable tablet 400mg + 20mg, charcoal 75mg+fungal diastase 100mg+papain 60mg tablet, dexrabeprazole and domperidone tablet 10mg + 30mg, aluminium hydroxide 830mg+simethicone 50mg+magnesium hydroxide 185mg+sodium carboxymethylcellulose 100mg syrup/gel, dexrabeprazole 10mg+levosulpiride 75mg tablet, lactitol 66.67% syrup 100ml, mesalazine 1gm , lactitol monohydrate us-nf 10 gm, ispaghula husk ip 3.5 gm, hyoscine butyl bromide 10mg mefanamic acid 250mg, polyethylene glycol 4000 ip 14.6gactivated dimethicone ip 0.01gpotassium chloride ip 0.18gsodium bicarbonate ip 0.42gsodium chloride ip 0.36g anhydrous sodium sulfate bp 1.42g, polyethylene glycol 4000 ip 118gpotassium chloride ip 1.484gsodium bicarbonate ip 3.370gsodium chloride ip 2.93g anhydrous sodium sulfate bp 11.360g, acotiamide 300mg, aluminium hydroxide 300mg+magnesium aluminium silicate 50mg+magnesium 25mg+simethicone 25mg, bifidobacterium longum 90billion cfu+lactobacillus acidophilus+streptococcus thermophilus, bile constituents 25mg+dimethicone 40mg+pancreatin 192mg, clidinium 2.5mg+chlordiazepoxide 5mg+dicyclomine 10mg, activated dimethicone 80mg+pancreatin 170mg, domperidone 30mg+rabeprazole 40mg, drotaverine 80mg, drotaverine 80mg+mefenamic 250mg, esomeprazole 40mg+itopride 150mg, fungal diastase 18.75mg+pepsin 12.5mg, itopride 150mg, lactulose 3.335gm, lansoprazole 15mg, mesalazine 2000mg, oxetacaine 10mg+sucralfate 1000mg, oxetacaine 10mg+sucralfate 500mg, pancreatin 170mg+sodium tauroglycocholate 65mg, pancreatin 300mg, saccharomyces boulardii 250mg, simethicone 80mg+pancreatin 170mg, sucralfate 500mg, ethi

Corporations And Associations And Others

CTN :35500609 Due date: 31 May, 202431 May, 2024 NA
Tender For corrigendum : tender for the supplies of drugs and pharmaceuticals, labchemicals, x ray films and chemicals, surgicalsutures and dressings, vaccines, sera etc. and general items for the year 2023 25. - inj: 17 hydroxy progesterone caproate 500 mg., inj: 17 hydroxy progesterone caproate 250 mg, inj: acyclovir 250 mg., inj: adenosine 6mg/2ml, inj: adrenaline 1:1000, inj: amino acid 10%, infusion: amio acid solution i.v, inj: amiodarone 150 mg/3ml, inj: anti diptheria serrum 10,000 i.u. vial, inj: anti rabies-human rabies immunoglobin 2ml (300 i.u.) pfs, inj: anti rabies-immune serum - 300 iu/ml (equine) immunoglobin, inj: anti rabies-monoclonal antibodies , inj: anti snake serum (polyvalent), inj: benzathine penicilline 12 lakhs, inj: betamethasone 4 mg., inj: calcium gluconate (10% w/v), inj: carboprost tromethamine 250 mcg/ml, inj: carboprost tromethamine125 mcg/ml, inj: ceftriaxone sodium 1000 mg + disodium edetate 37 mg + sulbactum 500 mg, inj: ceftriaxone sodium 1000 mg + disodium edetate 74 mg + sulbactum 1000 mg, inj: dexamethasone sod. phosphate 4 mg/ ml., iv fluid: dextose 5% in fractional saline 0.45% (ffs technology) - each 100 ml. contains - dextrose anhydrous ip 5.0 gm. + sodium chloride ip 0.45 gm. +water for inj ip qs., iv fluid: dextrose inj ip 10% (ffs technology) - each 100 ml. contains - dextrose anhydrous ip 10.0 gm.+ water for inj ip qs., iv fluid: dextrose inj ip 25% (ffs technology) - each 100 ml. contains - dextrose anhydrous ip 25.0 gm.+ water for inj ip qs., inj: diazepam 5 mg/ ml, inj: diclofenac sod,. 25 mg/ ml, inj: diclofenac sodium 75 mg/ml, 1ml inj iv bolus, surfactant free inj, inj: dicyclomine 10 mg/ ml, inj: dobutamine hcl 250 mg/ vial, inj: dopamine 200 mg/ amp.. (40 mg./ml.), inj: drotaverine 20 mg/ml, inj: drotaverine 40 mg, insulin: dulagutide 1.5mg , inj: each 0.9ml contains: atosiban acetate ip equivalent to atosiban 6.75 mg water for inj ip q.s., inj: each 0.9ml contains: atosiban acetate ip equivalent to atosiban 37.5 mg water for inj ip q.s., inj: each ml contains human insulin ip 100 iu (30% as soluble insulin inj and 70% as isophane insulin inj) (human insulin of recombinant dna origin), inj: each ml contains human insulin ip 100 iu (human insulin of recombinant dna origin), inj: each ml contains human insulin ip 100 iu (insulin, human of recombinant dna origin) inj, inj: each ml contains human insulin ip 40 iu (30% as soluble insulin inj and 70% as isophane insulin inj) (human insulin of recombinant dna origin) inj, inj: each ml contains human insulin ip 40 iu (human insulin of recombinant dna origin), inj: each ml contains insulin glargine (rdna origin) 100 iu, inj: each ml contains insulin glargine (rdna origin) 100 iu, inj: each ml contains insulin glargine (rdna origin) 100 iu, inj: each ml of 50% insulin lispro and 50% insulin lispro protamine suspension contins 100 i.u. (equivalent to 3.5 mg) insulin lispro i.p. (r-dna origin), inj: each ml of insulin lispro contains 100 i.u. (equivalent to 3.5 mg) insulin lispro i.p. (r-dna origin), inj: enoxaparin in prefilled syringe in strength of 0.4 ml, inj: enoxaparin in prefilled syringe in strength of 0.6 ml, inj: erythropoitin 2000 units(recombinant (human), inj: erythropoitin 4000 units(recombinant (human), inj: ethamsylate 125 mg/ ml, inj: etophylline 169. 4 mg + theophylline 50.6 mg per 2 ml. amp., inj: ferric carboxymaltose ( elemental iron- 50 mg/ml), inj: fondaparinoaux 2.5 mg , inj: frusemide 10 mg/ml., inj: hepatitis b surface antigen recombinant/ 20 mcg/ ml., infusion: human albumin 20% , inj: human chorionicgonadotropin 5000 iu (hormone), inj: hydrocortisone sod.succinate 100 mg/ ml., inj: hyoscine butyl bromide 20 mg/ ml, inj: insulin aspart 100 iu/ml. (insulin analogue short acting), inj: insulin aspart 100u/ml for inj in 10ml, inj: insulin aspart 100u/ml for inj in 3ml , inj: insulin glargine 100units/ml, inj: insulin lispro 25% + lispro protamine 75%, inj: iron sucrose 100 mg, inj: isoxsuprine 5 mg/ ml, inj: labetalol 5
 Loading, Please wait...

Connect us via What's Up